Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovative Neutronics is a medical technology company focused on advancing Boron Neutron Capture Therapy (BNCT) through the development of compact, accelerator-based neutron sources. The company aims to overcome the historical limitations of BNCT, which previously required large nuclear reactors, by providing hospital-sited systems that are both cost-effective and efficient. Their core technology centers on a high-flux neutron generator designed to deliver precise therapeutic doses to tumor sites. By combining these neutron sources with boron-10 delivery agents, Innovative Neutronics targets aggressive and recurrent cancers, including glioblastoma multiforme and head and neck malignancies. The company is positioned at the intersection of nuclear physics and oncology, striving to make targeted neutron therapy a standard clinical option.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovative Neutronics.